🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05308641
Active, not recruiting Not applicable

Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain

NCT05308641 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2022-09-18
Last updated
2025-04-06

Condition(s) studied

Chronic Low-back Pain (cLBP)

Investigational drug(s) / intervention(s)

radial extracorporeal shockwave therapy_4000_20radial extracorporeal shockwave therapy_500_2standard multimodal pain therapy

radial extracorporeal shockwave therapy_4000_20: application of radial extracorporeal shockwave therapy (rESWT) with 4000 pulses and 20 Hz

radial extracorporeal shockwave therapy_500_2: application of radial extracorporeal shockwave therapy (rESWT) with 500 pulses and 2 Hz

standard multimodal pain therapy: standard multimodal pain therapy

Study summary

Analysis of the effectiveness of radial shock wave therapy as part of a multimodal pain therapy in the inpatient setting. Different therapy protocols are compared in previously non-operated and in previously operated patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * chronic lumbar back pain of min 3 months duration Exclusion Criteria: * radicular pain of higher intensity than chronic low back pain (cLBP) * new neurologic deficits * anticoagulant therapy * new trauma to the lumbar spine * spine bacterial infection * spine tumor * pregnancy * coagulation disorder * previous infiltration to the lumbar spine within 6 weeks prior to study inclusion * fibromyalgia

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Klinik Blankenstein Hattingen Germany

More Ruhr University of Bochum trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05308641 on ClinicalTrials.gov ↗ ← All trials in Germany